Project information

NISCI - Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial (NISCI)

Investor logo
Project Identification
681094
Project Period
1/2019 - 12/2020
Investor / Pogramme / Project type
European Union
MU Faculty or unit
Faculty of Medicine
Cooperating Organization
University Hospital Prague - Motol
Ruhr-Universität Bochum
Universität Zürich
European Clinical Research Infrastructures Netwo
Heidelberg University Hospital

Antibodies against Nogo-A to enhance plasticity, regeneration and functional recovery after acute spinal cord injury, a multicenter European randomized double blinded placebo controlled phase II clinical proof of concept trial.